These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253 [TBL] [Abstract][Full Text] [Related]
4. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849 [TBL] [Abstract][Full Text] [Related]
5. Expression of deltaNp63 in squamous cell carcinoma of the esophagus. Morita M; Uramoto H; Nakata S; Ono K; Sugaya M; Yoshimatsu T; Oyama T; Hanagiri T; Sugio K; Yasumoto K Anticancer Res; 2005; 25(5):3533-9. PubMed ID: 16101176 [TBL] [Abstract][Full Text] [Related]
6. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of p63 in esophageal Barrett's adenocarcinoma. Hara T; Kijima H; Yamamoto S; Kise Y; Hanashi T; Nishi T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H Mol Med Rep; 2008; 1(4):473-7. PubMed ID: 21479434 [TBL] [Abstract][Full Text] [Related]
8. Expression profiles of p63, p53, survivin, and hTERT in skin tumors. Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709 [TBL] [Abstract][Full Text] [Related]
9. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069 [TBL] [Abstract][Full Text] [Related]
10. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance]. Hu WF; Liu MQ; Zhao Q Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194 [TBL] [Abstract][Full Text] [Related]
11. p63 expression profiles in human normal and tumor tissues. Di Como CJ; Urist MJ; Babayan I; Drobnjak M; Hedvat CV; Teruya-Feldstein J; Pohar K; Hoos A; Cordon-Cardo C Clin Cancer Res; 2002 Feb; 8(2):494-501. PubMed ID: 11839669 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma. Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954 [TBL] [Abstract][Full Text] [Related]
13. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas. Chen YK; Hsue SS; Lin LM Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414 [TBL] [Abstract][Full Text] [Related]
14. p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice. Suliman Y; Opitz OG; Avadhani A; Burns TC; El-Deiry W; Wong DT; Rustgi AK Cancer Res; 2001 Sep; 61(17):6467-73. PubMed ID: 11522642 [TBL] [Abstract][Full Text] [Related]
15. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Kim S; Han J; Kim J; Park C Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179 [TBL] [Abstract][Full Text] [Related]
16. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization. Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688 [TBL] [Abstract][Full Text] [Related]
17. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Usami Y; Chiba H; Nakayama F; Ueda J; Matsuda Y; Sawada N; Komori T; Ito A; Yokozaki H Hum Pathol; 2006 May; 37(5):569-77. PubMed ID: 16647955 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. de Oliveira LR; Ribeiro-Silva A; Zucoloto S J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296 [TBL] [Abstract][Full Text] [Related]
19. P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression. Preto A; Reis-Filho JS; Ricardo S; Soares P Pathol Res Pract; 2002; 198(7):449-54. PubMed ID: 12234063 [TBL] [Abstract][Full Text] [Related]
20. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation. Bratthauer GL; Saenger JS; Strauss BL Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]